|
|
||||||||
American Journal of Clinical Nutrition, Vol 55, 211S-214S, Copyright © 1992 by The American Society for Clinical Nutrition, Inc
REVIEW ARTICLES |
T Silverstone and E Goodall
Academic Unit of Human Psychopharmacology, Medical College of St Bartholomew's Hospital, London, UK.
This paper reviews the anorectic activity and effectiveness of catecholamine and serotoninergic anorectic drugs in the management of obesity. It discusses the clinical implications of the experimental findings and suggests prescribing strategies for effective long-term therapeutic benefit. The authors advocate that there is a role for the recently developed serotonin-mediated anorectic compounds in the treatment of obesity, particularly in those individuals with abnormal glucose tolerance or who are hypertensive.
This article has been cited by other articles:
![]() |
X. Lin, D. A. Levitsky, J. M. King, and T. C. Campbell The promotion effect of anorectic drugs on aflatoxin B1-induced hepatic preneoplastic foci Carcinogenesis, September 1, 1999; 20(9): 1793 - 1799. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |